glp-1 coverage news insurers Medicare obesity drug starting July 1 Insurance coverage just changed for

It is contraindicated in patients with active malignancy or diabetic retinopathy

Take the missed dose as soon as you remember, unless its close to your next scheduled dose

Building on the findings from the SURMOUNT-OSA trial, which demonstrated tirzepatides efficacy in improving OSA in nondiabetic patients, this study investigated whether OSA modifies the mortality benefit associated with GLP-1 use among individuals with diabetes in a large, real-world population

Oral semaglutide (Rybelsus) is also available for diabetes management

I am trying not to give up, though I have to be frank and say that after 40 years of this with zero help from medicine, standard or alternative, it's a bit hard not to get depressed